Updated Rumor Mill: Dutch Organon BioSciences Possibility — Takeda?

UPDATED: Saturday Evening — More from an anonymous source — in comments:

. . . .Various newssources say Takeda wants to take over some R&D people, around 200 to 300.

It would leave 1,800 people to be fired after February 2011. It’s said that Takeda is the only company talking with Merck at the HQ of Merck. So the role of Supervisory Board in the negotiations in The Netherlands is unclear to me.

December 18, 2010 5:44 PM. . . .


I don’t doubt the veracity here, but it is an unconfirmed, off-the-record source (an anonymous comment — left in my box, very early this morning):

. . . .Anonymous said:

Latest news it seems that Takeda is the interested party! Other parties no longer interested. . .

December 18, 2010 5:50 AM. . . .

We’ll keep you posted — could Takeda emerge as the intact buyer, here by mid-February 2011? Takeda is facing a fearsome exclusivity/patent cliff on its oral type II diabetis drug, Actos® (pioglitazone), come early 2011.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s